Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
Clinician,Deflazacort,Duchenne muscular dystrophy,"Deflazacort (Calcort,ZAMENE)",Recommended for decline,Community and Hospital,Musculoskeletal System
